Newstral
Article
The Jerusalem Post (JPost.com) on 2019-12-19 02:18
FDA grants approval for Astellas, Seattle Genetics' bladder cancer drug
Related news
- MSeattle Genetics' stock rises on approval of bladder cancer drugmarketwatch.com
- SFDA grants full approval to Pfizer-BioNTech COVID vaccinestarherald.net
- GFDA Grants First COVID-19 Vaccine Approval to Pfizer-BioNTechGuardian Liberty Voice
- Seattle Genetics drug wins FDA approval, could boost biotech's revenuebizjournals.com
- U.S. FDA Grants Full Approval to Pfizer-BioNTech Covid-19 Vaccinelongislandpress.com
- U.S. FDA grants full approval to Pfizer-BioNTech COVID-19 vaccineamny.com
- FDA Grants New Coronavirus Test Emergency Approvalwsj.com
- Seattle Genetics wins FDA approval for cancer drug that could push U.S. sales past $1 billionbizjournals.com
- PSientra wins new FDA approvalpacbiztimes.com
- MSeattle Genetics stock jumps 6% after new FDA approval for lymphoma treatmentmarketwatch.com
- Seattle Genetics preps for FDA approval of cancer drug that could push sales past $1Bbizjournals.com
- Seattle Genetics wins FDA approval for fourth application of flagship drugbizjournals.com
- PFDA grants full approval to Pfizer-BioNTech COVID-19 vaccinepagosasun.com
- FDA grants emergency approval to experimental COVID-19 antibody therapynewatlas.com
- BFDA Grants Full Approval to Gilead Breast Cancer Drugbarrons.com
- FDA grants accelerated approval to Sarepta’s Duchenne drugbizjournals.com
- FDA Grants Full Approval to the Pfizer Vaccinejdsupra.com
- FDA grants lymphoma cancer treatment in dogs full approvalFox News
- MPfizer vaccine gets FDA approvalmahometdaily.com